Please provide your email address to receive an email when new articles are posted on . The first presentation given at ACR Convergence 2024 that she spoke about evaluated the association between RA ...
This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...
SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that complete ...
New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced ...
Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...
Whether you are seeking information for yourself or a loved one, read on to learn more about the disease and how to better understand its signs and symptoms. Rheumatoid arthritis is an inflammatory ...
Dr. Chidiebere D. Akusobi (Medicine): A 44-year-old woman was evaluated in the rheumatology clinic of this hospital because of proximal muscle weakness and myalgia. The patient had been in her usual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results